Schedule 13G ownership disclosure
CytomX Therapeutics Inc
Security class unavailable · CUSIP: 23284F105
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 6,303,025
- Percent of class
- 9.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000899140-22-000335
- Form type
- SC 13G
- Filer
- CytomX Therapeutics, Inc.
- CIK
- CIK 1501989
- Filed
- Feb 14, 2022
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership